Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | T343J | — |
expired dose administration of Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number T343J, expiry date 25-JAN-2025) for prophylaxis. On 27-FEB-2025, the patient received Kinrix. On 27-FEB-2025, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: expired dose administration of Kinrix). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-FEB-2025 The Vaccine Administration Facility is the same as Primary Reporter. The registered nurse reported an expired dose administration of Kinrix which led to expired vaccine used. The Health Care Provider mentioned that they received three expired doses of Kinrix from another clinic and they were doing an investigation. Only reported one expired dose administration.